Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of MIST and INSURE for respiratory distress syndrome
IRCT20240602061980N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jun 2024
- Countries
- 1
01
Overview
Phase 3 trial of bovactant in respiratory distress syndrome (RDS) (2 arms), sponsored by Babol University of Medical Sciences. Started Jun 2024; status: completed.
02
Drugs
bovactant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20240602061980N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240602061980N1.